These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11287764)

  • 1. Platelet-activating factor antagonist, SM-12502, attenuates experimental glomerular thrombosis in rats.
    Hayashi J; Hiromura K; Koizumi R; Shimizu Y; Maezawa A; Nojima Y; Naruse T
    Nephron; 2001 Mar; 87(3):274-8. PubMed ID: 11287764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
    Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
    Komuro Y; Imanishi N; Uchida M; Morooka S
    Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats.
    Murakami K; Okajima K; Uchiba M; Johno M; Okabe H; Takatsuki K
    Thromb Haemost; 1996 Jun; 75(6):965-70. PubMed ID: 8822594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
    Natsume Y; Imanishi N; Koike H; Morooka S
    Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the reversed passive Arthus and local Shwartzman reactions of rabbit skin: effects of the long-acting PAF antagonist UK-74,505.
    Norman KE; Williams TJ; Rossi AG
    Br J Pharmacol; 1997 Apr; 120(7):1286-93. PubMed ID: 9105704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SM-12502 on disseminated intravascular coagulation (DIC) in tumor-bearing rats.
    Morooka S; Natsume Y
    Adv Exp Med Biol; 1996; 416():189-93. PubMed ID: 9131147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective glomerular thrombosis in rats induced by combined injections of nephrotoxic antiserum and lipopolysaccharide.
    Naruse T; Tsuchida A; Ogawa S; Yano S; Maekawa T
    J Lab Clin Med; 1985 Feb; 105(2):146-56. PubMed ID: 3882861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: importance of PAF.
    Bernat A; Herbert JM
    Thromb Res; 1994 Jul; 75(1):91-7. PubMed ID: 8073411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers.
    Hill ME; Bird IN; Daniels RH; Elmore MA; Finnen MJ
    J Immunol; 1994 Oct; 153(8):3673-83. PubMed ID: 7930587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils.
    Todoroki H; Higure A; Okamoto K; Okazaki K; Nagafuchi Y; Takeda S; Katoh H; Itoh H; Ohsato K; Nakamura S
    J Surg Res; 1998 Dec; 80(2):149-55. PubMed ID: 9878306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney.
    Perico N; Delaini F; Tagliaferri M; Abbate M; Cucchi M; Bertani T; Remuzzi G
    Lab Invest; 1988 Feb; 58(2):163-71. PubMed ID: 3123798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular platelet-activating factor levels and origin in experimental glomerulonephritis.
    Lianos EA; Zanglis A
    Kidney Int; 1990 Feb; 37(2):736-40. PubMed ID: 2308260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of platelet-activating factor in renal immune injury and proteinuria.
    Perico N; Remuzzi G
    Am J Nephrol; 1990; 10 Suppl 1():98-104. PubMed ID: 2256482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor.
    De Plaen IG; Tan XD; Chang H; Wang L; Remick DG; Hsueh W
    Br J Pharmacol; 2000 Jan; 129(2):307-14. PubMed ID: 10694237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury.
    Miotla JM; Jeffery PK; Hellewell PG
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):197-204. PubMed ID: 9476906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-activating activity and platelet-activating factor synthesis in cytokine-stimulated endothelial cells: reduced activity in growth-arrested cells.
    Takahashi T; Nishizawa Y; Hato F; Shintaku H; Maeda N; Fujiwara N; Inaba M; Kobayashi K; Kitagawa S
    Microvasc Res; 2007 Jan; 73(1):29-34. PubMed ID: 17027041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Neutrophil Granulocytes by Platelet-Activating Factor Is Impaired During Experimental Sepsis.
    Hug S; Bernhard S; Stratmann AEP; Erber M; Wohlgemuth L; Knapp CL; Bauer JM; Vidoni L; Fauler M; Föhr KJ; Radermacher P; Hoffmann A; Huber-Lang M; Messerer DAC
    Front Immunol; 2021; 12():642867. PubMed ID: 33796110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
    Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
    Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.